(Q40872614)

24 September 2017

1 reference

title

Biology and management of the midgut carcinoid (English)

1 reference

24 September 2017

2

Ahlman H

1 reference

24 September 2017

4

Modlin IM

1 reference

24 September 2017

Basson MD

1

1 reference

24 September 2017

Wangberg B

series ordinal

3

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 February 1993

1 reference

The American Journal of Surgery

24 September 2017

published in

1 reference

24 September 2017

volume

165

1 reference

24 September 2017

issue

2

1 reference

24 September 2017

page(s)

288-297

1 reference

Ueber den primären Krebs des Ileum nebst Bemerkungen über das gleichzeitige Vorkommen von Krebs und Tuberculose

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

5-Hydroxytryptamine in a Carcinoid Tumour

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

5-Hydroxytryptophan Uptake by Dog Thyroid ‘C’ Cells, and its Possible Significance in Polypeptide Hormone Production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Common cytochemical properties of cells producing polypeptide hormones, with particular reference to calcitonin and the thyroid C cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. III. Entero-endocrine cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Derivation of mouse intestinal crypts from single progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Clonal origin of columnar, mucous, and endocrine cell lineages in human colorectal epithelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Comparison of immunological detection of 5-hydroxytryptamine by monoclonal antibodies with standard silver stains as an aid to diagnosing carcinoid tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Carcinoid tumors and the carcinoid syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

New Understanding of the Mechanism of the Carcinoid Flush

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Carcinoid TumorsAn analysis of 2837 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Carcinoid tumors in Meckel's diverticula.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Concurrent collagenous colitis and multiple ileal carcinoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Malignant Carcinoid Tumour with Gangrene of the Small Intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Intestinal ischaemia associated with ileal carcinoid tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Intestinal infarction caused by carcinoid associated elastic vascular sclerosis: early presentation of a small ileal carcinoid tumour

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Radiologic diagnosis of ileal carcinoid tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Management of Disseminated Midgut Carcinoid Tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Somatostatin-receptor imaging in the localization of endocrine tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Carcinoid tumors: iodine-131 MIBG scintigraphy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Role of neuropeptides and serotonin in the diagnosis of carcinoid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

MALIGNANT CARCINOID TUMORS WITH AND WITHOUT FLUSHING

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

The carcinoid flush. Provocation by pentagastrin and inhibition by somatostatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

A possible mechanism for the release of serotonin from the gut caused by pentagastrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Pancreaticoduodenectomy for bleeding periampullary tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Life history of the carcinoid tumor of the small intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Pathologic analysis of carcinoids. Histologic reevaluation of 62 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

DNA distribution pattern in intestinal carcinoid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

A flow cytometric analysis of 23 carcinoid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Aggressive resection of metastatic disease in selected patients with malignant gastrinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Surgical treatment of functioning metastatic carcinoid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Effects of experimental hepatic artery embolization on hepatic function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Hepatic artery embolization in the treatment of hepatic neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Treatment of carcinoid liver metastases by hepatic-artery embolisation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Carcinoid syndrome treated by hepatic embolization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Control of carcinoid syndrome with hepatic artery embolization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Evaluation of temporary liver dearterialization and embolization in patients with metastatic carcinoid tumour

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Liver transplantation for primary and secondary hepatic apudomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Metastatic carcinoid tumors and the carcinoid syndrome. A selective review of chemotherapy and hormonal therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

A study of cyproheptadine in the treatment of metastatic carcinoid tumor and the malignant carcinoid syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Effects of Leukocyte Interferon on Clinical Symptoms and Hormone Levels in Patients with Mid-Gut Carcinoid Tumors and Carcinoid Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Treatment of malignant metastatic midgut carcinoid tumours with recombinant human alpha2b interferon with or without prior hepatic artery embolization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Therapy of metastatic carcinoid tumor and the malignant carcinoid syndrome with recombinant leukocyte A interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Is the treatment of metastatic carcinoid tumor with interferon not as successful as suggested?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Treatment of malignant carcinoid tumors with recombinant interferon alfa-2b: development of neutralizing interferon antibodies and possible loss of antitumor activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Somatostatin inhibits rapid centrosomal separation and cell proliferation induced by epidermal growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Inhibition of growth of two human pancreatic adenocarcinomas in vivo by somatostatin analog SMS 201-995.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

NIH conference. Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

The effect of a somatostatin analogue on the release of hormones from human midgut carcinoid tumour cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Somatostatin inhibits diarrhea in the carcinoid syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

7 January 2021

The carcinoid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Fatal carcinoid crisis after percutaneous fine-needle biopsy of hepatic metastasis: case report and literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Limitations of angiography for mesenteric ischemia caused by midgut carcinoid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Adenocarcinoid, a mucin-producing carcinoid tumor of the appendix: a study of 39 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Composite (adenocarcinoid) tumors of the gastrointestinal tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

Carcinoid tumor of the appendix: treatment and prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980529-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9610(05)80529-X

1 reference

release_h4pzjlbgabdojo24cxleck6k64

24 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/h4pzjlbgabdojo24cxleck6k64

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference